Jerusalem Post Israel News

Share

Jerusalem Post Israel News

 •  October 20, 2017

American regulators granted approval on Wednesday to a gene-altering treatment for patients suffering from lymphoma, the second-ever approval for a gene therapy procedure and one that could revolutionize how we fight cancer. The drug, named Yescarta, was developed by Israeli-founded Kite Pharma and it is expected to cost some $373,000, likely...

Jerusalem Post Israel News

 •  October 13, 2017

Teva Pharmaceutical Industries took a huge financial hit on Wednesday when the US Food and Drug Administration approved a competitor’s generic version of its highly profitable multiple sclerosis drug. Mylan NV received the green light to produce a copycat version of Teva’s blockbuster drug, Copaxone, which is already on its way to American...

Jerusalem Post Israel News

 •  July 2, 2017

An algorithm that cuts through the immense number of possible solutions to shorten drug discovery times from years to months has been developed by Hebrew University of Jerusalem scientists and is expected to lead to dramatic improvement in drug discovery methods. For his work on the algorithm, Prof. Amiram Goldblum of the Institute for Drug...